欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1272/001
药品名称
Gliclazida Lupin
活性成分
gliclazide 60.0 mg
剂型
Modified-release tablet
上市许可持有人
Lupin (Europe) Ltd
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Poland (PL)
Glikuron
Lithuania (LT)
Gliclazide Ingen Pharma 60 mg pailginto atpalaidavimo tabletės
Bulgaria (BG)
Gliclazide Lupin
Romania (RO)
Gliclazida Lupin 60 mg comprimate cu eliberare prelungita
许可日期
2015/07/01
最近更新日期
2023/06/14
药物ATC编码
A10BB09 gliclazide
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common-impack-clean
Date of last change:2015/11/25
Final Product Information
|
common-outer-clean
Date of last change:2015/11/25
Final Product Information
|
common-pl-clean
Date of last change:2015/11/25
Final Product Information
|
common-spc-clean
Date of last change:2015/11/25
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase